Cases & Deals

JumpStart invests in Thermalin Diabetes

Clients JumpStart Inc.

Jones Day advised JumpStart Inc. in connection with its purchase of a Secured Convertible Promissory Note in a private placement by Thermalin Diabetes, Incorporated, a developer of portfolios of insulin analogs to address both the fast-acting and long-acting insulin markets.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.